HAPH Registry: Study on lung artery pressure in high-altitude residents
Part of Brain & nervous system, Heart & circulation, Lungs & breathing clinical trials.
This study is for people living at high altitudes (above 2,500 meters) to understand how the pressure in the arteries of the lungs changes over time and how it affects health. It may help doctors predict and manage heart and lung problems that can occur in high-altitude residents.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live permanently at an altitude above 2,500 meters (about 8,200 feet).
- You are willing and able to give your written consent to participate.
- You do not have a moderate or severe lung disease, such as COPD or serious scarring of the lungs.
- You do not smoke more than 20 cigarettes a day or have a very heavy smoking history (more than 20 pack-years).
- You do not have unstable high blood pressure or coronary artery disease that needed medication changes in the last 2 months.
- You do not take medications like benzodiazepines, opioids, or acetazolamide (Diamox) that affect your breathing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a common heart feature, called a patent foramen ovale (a small flap between the upper chambers), affects the heart's response to low oxygen, such as at high altitudes. Participation may help researchers understand why some people develop fluid in the lungs at high altitude and could lead to better prevention or treatment.
This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.
This trial tests if Advair HFA affects how likely someone is to develop High Altitude Pulmonary Edema (HAPE), a serious lung condition at high altitudes. It compares people who are prone to HAPE, those who are resistant, and healthy controls.
This study collects information from people with rare types of pulmonary hypertension (high blood pressure in the lungs) and from healthy volunteers. It helps researchers better understand these conditions, especially using a special lung-heart test to confirm the diagnosis.
This study follows pregnant women living at high altitude in Bolivia to understand how pregnancy differs from those at sea level. It may help improve care for mothers and babies in high-altitude regions.
This study uses an echocardiogram (heart ultrasound) to check for high blood pressure in the lungs (pulmonary hypertension) in people with obstructive sleep apnea. It may help find hidden heart strain in sleep apnea patients.
Hear when a new Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.